About

About TBMC Taiwan Bio-Manufacturing Corporation (TBMC), founded in May 2023, specializes in advanced biotechnology, including mRNA, viral vectors, cell therapies, and biologics. Committed to high-quality biomanufacturing, TBMC offers end-to-end mRNA production, covering plasmid DNA, sequence optimization, IVT, and LNP formulation. Our viral vector services support research and preclinical development, while our cell therapy platform enables large-scale MSC and cancer immunotherapy production. For biologics, our proprietary CHO-C platform accelerates protein production and process development. Backed by innovation and expertise, TBMC helps biotech companies transition seamlessly to manufacturing.